GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IVIM Technology Inc (XKRX:460470) » Definitions » Change In Working Capital

IVIM Technology (XKRX:460470) Change In Working Capital : ₩-3,552 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is IVIM Technology Change In Working Capital?

IVIM Technology's change in working capital for the quarter that ended in Mar. 2025 was ₩-627 Mil.

IVIM Technology's change in working capital for the fiscal year that ended in Dec. 2024 was ₩-4,773 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).


IVIM Technology Change In Working Capital Historical Data

The historical data trend for IVIM Technology's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVIM Technology Change In Working Capital Chart

IVIM Technology Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Change In Working Capital
-1,628.09 -1,951.12 -2,268.51 -4,772.86

IVIM Technology Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1,848.49 -551.54 -1,313.73 -1,059.10 -627.26

IVIM Technology Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-3,552 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IVIM Technology Change In Working Capital Related Terms

Thank you for viewing the detailed overview of IVIM Technology's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


IVIM Technology Business Description

Traded in Other Exchanges
N/A
Address
Yuseong-gu Techno 4-ro 17, Daedeok Biz Center B-dong 408, 413, 414, 415, Gwanpyeong-dong, Daejeon Metropolitan City, KOR
IVIM Technology Inc is engaged in the manufacturing of cameras, other optical instruments, and photographic equipment. The company technology enables the analyze vivo efficacy of new biopharmaceuticals such as immunological, cell, gene, and antibody therapeutic agents acting in real living organisms at the cellular level.

IVIM Technology Headlines

No Headlines